GSK plc

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA GSK

Report date

6/30/2022

Quarter

2022 Q2

Filed

7/26/2022

Shares

9,830

Value ($000)

428

Weight

0.0%

2013 Q4 - 2022 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	7/26/2022	428	0.0%	9,830	6/30/2022
2022 Q1	4/13/2022	428	0.0%	9,830	3/31/2022
2021 Q4	2/14/2022	1,050	0.0%	23,800	12/31/2021
2021 Q3	11/12/2021	752	0.0%	19,670	9/30/2021
2021 Q2	8/13/2021	904	0.0%	22,710	6/30/2021
2021 Q1	4/14/2021	979	0.0%	27,421	3/31/2021
2020 Q4	1/14/2021	1,322	0.0%	35,932	12/31/2020
2020 Q3	10/15/2020	1,351	0.0%	35,887	9/30/2020
2020 Q2	7/30/2020	39	0.0%	950	6/30/2020
2020 Q1	4/15/2020	36	0.0%	950	3/31/2020
2019 Q4	1/22/2020	45	0.0%	950	12/31/2019
2014 Q1	4/28/2014	253	0.0%	4,729	3/31/2014
2013 Q4	2/11/2014	262	0.0%	4,904	12/31/2013